Concepedia

Publication | Closed Access

Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.

16

Citations

0

References

2014

Year

Sofia Palacio, Arturo Loaiza‐Bonilla, Muaiad Kittaneh, Christos P. Kyriakopoulos, Roberto Ochoa, Mauricio A. Escobar, Belisario A. Arango, María H. Restrepo, Jaime R. Merchan, Caio Max S. Rocha Lima,
PubMed

Abstract

Trastuzumab is an important agent for the treatment of HER2-overexpressing gastric cancer. We recorded an acceptable safety and efficacy profile in this small cohort treated with anthracycline-based chemotherapy with trastuzumab followed by trastuzumab maintenance.